Gabelli Upgrades Iterum Therapeutics (ITRM) to Hold
Tweet Send to a Friend
Gabelli analyst Kevin Kedra upgraded Iterum Therapeutics (NASDAQ: ITRM) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
